BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 31030335)

  • 1. LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p/SPARC axis in papillary thyroid cancer.
    Liang M; Jia J; Chen L; Wei B; Guan Q; Ding Z; Yu J; Pang R; He G
    Endocrine; 2019 Aug; 65(2):318-326. PubMed ID: 31030335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA MCM3AP-AS1 promotes growth and migration through modulating FOXK1 by sponging miR-138-5p in pancreatic cancer.
    Yang M; Sun S; Guo Y; Qin J; Liu G
    Mol Med; 2019 Dec; 25(1):55. PubMed ID: 31830901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D; Zheng Y
    Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA MCM3AP-AS1 enhances cell proliferation and metastasis in colorectal cancer by regulating miR-193a-5p/SENP1.
    Zhou M; Bian Z; Liu B; Zhang Y; Cao Y; Cui K; Sun S; Li J; Zhang J; Wang X; Li C; Yao S; Yin Y; Fei B; Huang Z
    Cancer Med; 2021 Apr; 10(7):2470-2481. PubMed ID: 33686713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA
    Nian R; Li W; Li X; Zhang J; Li W; Pan F; Cheng J; Jin X
    Arch Endocrinol Metab; 2023 Jan; 67(1):55-63. PubMed ID: 35929906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p.
    Hou S; Lin Q; Guan F; Lin C
    J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA MCM3AP-AS1 inhibits the progression of colorectal cancer via the miR-19a-3p/FOXF2 axis.
    Dai W; Zeng W; Lee D
    J Gene Med; 2021 Mar; 23(3):e3306. PubMed ID: 33450091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis.
    Chen N; Yin D; Lun B; Guo X
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30429236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA PITPNA-AS1 regulates UNC5B expression in papillary thyroid cancer via sponging miR-129-5p.
    Mei S; Zong H; Zhou H
    Int J Biol Markers; 2021 Mar; 36(1):10-19. PubMed ID: 33706585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA MCM3AP-AS1 sponges miR-148a to enhance cell invasion and migration in small cell lung cancer.
    Luo H; Zhang Y; Qin G; Jiang B; Miao L
    BMC Cancer; 2021 Jul; 21(1):820. PubMed ID: 34271873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YY1-mediated overexpression of long noncoding RNA MCM3AP-AS1 accelerates angiogenesis and progression in lung cancer by targeting miR-340-5p/KPNA4 axis.
    Li X; Yu M; Yang C
    J Cell Biochem; 2020 Mar; 121(3):2258-2267. PubMed ID: 31693222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MCM3AP-AS1 promotes breast cancer progression via modulating miR-28-5p/CENPF axis.
    Chen Q; Xu H; Zhu J; Feng K; Hu C
    Biomed Pharmacother; 2020 Aug; 128():110289. PubMed ID: 32485570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MCM3AP-AS1 promotes proliferation, migration and invasion of oral squamous cell carcinoma cells via regulating miR-204-5p/FOXC1.
    Li H; Jiang J
    J Investig Med; 2020 Oct; 68(7):1282-1288. PubMed ID: 32690597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CERS6-AS1 Facilitates Oncogenesis and Restrains Ferroptosis in Papillary Thyroid Carcinoma by Serving as a ceRNA through miR-497-5p/LASP1 Axis.
    Huang T; Guan S; Wang C
    Ann Clin Lab Sci; 2022 May; 52(3):426-438. PubMed ID: 35777805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA LIFR-AS1 suppressed the proliferation, angiogenesis, migration and invasion of papillary thyroid cancer cells via the miR-31-5p/SIDT2 axis.
    Yi D; Zhang D; He J
    Cell Cycle; 2021 Dec; 20(24):2619-2637. PubMed ID: 34781815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA MCM3AP antisense RNA 1 promotes non-small cell lung cancer progression through targeting microRNA-195-5p.
    Shen D; Li J; Tao K; Jiang Y
    Bioengineered; 2021 Dec; 12(1):3525-3538. PubMed ID: 34346845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
    Chen Y; Gao H; Li Y
    Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of MCM3AP-AS1 targeted the regulation of miR-708-5p on cell proliferation and apoptosis in gastric cancer cells.
    Wang H; Xu T; Wu L; Xu HL; Liu RM
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2452-2461. PubMed ID: 32196596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNAs SET-binding factor 2-antisense RNA1 promotes cell growth through targeting miR-431-5p/CDK14 axis in human papillary thyroid cancer.
    Wen HL; Xu ZM; Wen D; Lin SY; Liang Y; Xie JP
    Kaohsiung J Med Sci; 2020 Oct; 36(10):808-816. PubMed ID: 32602632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.